Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
about
Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cellsSubcellular localization and tumor-suppressive functions of 15-lipoxygenase 2 (15-LOX2) and its splice variants12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stressImmunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changesInverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epitheliaThe chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrumIdentification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.PPARs and the cardiovascular systemCD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6).The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.The in vitro real-time oscillation monitoring system identifies potential entrainment factors for circadian clocks.Eicosanoid storm in infection and inflammationNuclear receptors in bone physiology and diseasesOxidized PLs and vascular inflammationAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsT cells in atherosclerosisInhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-γ and down-regulation of VEGFR-2 expressionThe epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivoThe nuclear receptor PPARγ individually responds to serotonin- and fatty acid-metabolitesLipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review)Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-γ in CD36 Protein Expression and Foam Cell FormationTumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytesA novel pathway involving progesterone receptor, 12/15-lipoxygenase-derived eicosanoids, and peroxisome proliferator-activated receptor gamma regulates implantation in miceOxidized lipids and lysophosphatidylcholine induce the chemotaxis, up-regulate the expression of CCR9 and CXCR4 and abrogate the release of IL-6 in human monocytesMammalian lipoxygenases and their biological relevanceBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acidOmega-3 Fatty Acids and PPARgamma in CancerFunctional and pathological roles of the 12- and 15-lipoxygenasesStatin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IFrom estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosisEpidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activityThe fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activitiesA novel group of phospholipase A2s preferentially expressed in type 2 helper T cellsThe effects of estrogen and testosterone on gene expression in the rat mesenteric arteriesDifferential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowelThe binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoproteinMacrophage-specific PPARgamma controls alternative activation and improves insulin resistanceNonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetesInterleukin-4 induction of the CC chemokine TARC (CCL17) in murine macrophages is mediated by multiple STAT6 sites in the TARC gene promoter.Novel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.
P2860
Q24292284-C5C67174-9AB4-4FE5-B228-9B6412E9BD4BQ24300188-D99A228E-9F2B-42FD-A2C7-6B9BFD41B37EQ24338241-C1AB6023-7CD2-4093-9241-30A9B4B1547DQ24532069-8CF9EB2B-B8BD-4118-A889-8DD3BA8363F7Q24550862-E99172F1-5FAF-45AC-AFBF-805862B316DFQ24606039-2DD8F5FC-38F8-4678-B79E-D142A5FD6DBEQ24606271-EC634642-5F73-41CF-BB08-1D65595E1D60Q24642728-8DB46A75-E940-4552-B478-C99DD33232BDQ24791158-4EF14242-D7E3-4FF4-AA89-725481A2F104Q24814517-C95103F8-7F23-400D-905A-DBF745ED8F37Q25256792-75FE4D26-1309-45E7-BC25-E837F22FDDF5Q26851985-9E42CA1A-0B50-42E7-84D9-B44095CCF15CQ26853017-A4C8197F-FF09-406E-9901-8233956DCCA6Q27013971-726D06E2-8DFF-40D5-920E-CDD9285362FFQ27014988-1A1B3B4F-2C9B-48E5-A90A-1FE47130C202Q27025697-F0B9F253-542B-4B28-839A-B1EE76025F2FQ27332433-153B47E1-DCDF-4BEC-B9DF-30BD4F546830Q27339662-02EBFD43-A94E-4BA2-85AC-F50CD7E7D417Q27664075-946B492C-0150-42CD-8E92-49D1200B28F1Q28083206-E5891D39-4FAF-4101-A18E-659801593ACEQ28115789-0B2456BE-9B22-49F9-B8D8-821E0F66D015Q28219857-02901948-9FCA-455C-8046-6D6519E91A3CQ28235394-2A874C24-07D3-4942-9D74-7775A44467EEQ28248592-DE39AF0D-6933-4CF2-B8A0-1A5449877A36Q28249730-325E764A-59BB-4373-93CD-8F33B8DDA1E3Q28252674-6106A9E9-CA4C-4529-9556-4686E0B0ABE2Q28292907-DE035787-9763-4DBC-A40E-BA55408DB265Q28296453-6AD4428F-D4FC-46CD-9650-11434A8B4E7EQ28366335-F09BCFA8-4698-48B8-B736-24188703E169Q28385120-14886244-E86C-46AA-B850-9307D2563F4DQ28512562-073DEB29-46A9-4FEC-994F-38172EF6A69FQ28513582-63A34992-E00C-4B96-A5A7-FD2AC170E4F0Q28513976-2211C86B-5DAE-4B29-9C6D-9DCD6BD62FF0Q28580106-0B4D4B86-593F-4CDD-91AA-EA6EFBF37937Q28583062-FCD98D29-65FC-48CB-8240-8CDB341F0C5CQ28647592-AC3CA0BA-9549-4C97-BDFF-4CB4B4107ABFQ29614354-1F48988C-03CD-400A-A6AC-83CE460A9A8FQ30434071-8D5E522F-A1E0-4CBB-9F5F-4C17089B6102Q30478469-E5CEBB04-881B-4245-8CC1-70A73D89568EQ30573092-5F64D144-59C0-4C90-8442-8991D86151FD
P2860
Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
description
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Nature
@fr
artículu científicu espublizáu en 1999
@ast
scientific journal article
@en
vedecký článok (publikovaný 1999/07/22)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/07/22)
@nl
наукова стаття, опублікована в липні 1999
@uk
مقالة علمية (نشرت في 22-7-1999)
@ar
name
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@ast
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@en
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@nl
type
label
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@ast
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@en
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@nl
prefLabel
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@ast
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@en
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@nl
P2093
P921
P356
P1433
P1476
Interleukin-4-dependent produc ...... rophages by 12/15-lipoxygenase
@en
P2093
Willson TM
Witztum JL
P2888
P304
P356
10.1038/22572
P407
P577
1999-07-01T00:00:00Z
P6179
1025963511